{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:57:33Z","timestamp":1781697453919,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K18400"],"award-info":[{"award-number":["24K18400"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.modpat.2026.101001","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:17:06Z","timestamp":1775841426000},"page":"101001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["p62\/SQSTM1 Accumulation Defines an Epithelial-Mesenchymal Transition (EMT)\/Twist1-Associated Infiltrative Phenotype in Pancreatic Neuroendocrine Tumors"],"prefix":"10.1016","volume":"39","author":[{"given":"Takashi","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Osajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Mizuuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keijiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Takigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Shimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohta","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Aishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.modpat.2026.101001_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the Incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"11","key":"10.1016\/j.modpat.2026.101001_bib2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00535-021-01827-7","article-title":"JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis","volume":"56","author":"Ito","year":"2021","journal-title":"J Gastroenterol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101001_bib3","first-page":"471","article-title":"Gastroenteropancreatic neuroendocrine tumors","volume":"68","author":"Cives","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.modpat.2026.101001_bib4","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1002\/cam4.2232","article-title":"CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors","volume":"8","author":"Miki","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.modpat.2026.101001_bib5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.canlet.2017.10.036","article-title":"Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor","volume":"412","author":"Gao","year":"2018","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.modpat.2026.101001_bib6","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.3390\/jcm14103389","article-title":"Treatment of pancreatic neuroendocrine tumors: beyond traditional surgery and targeted therapy","volume":"14","author":"Bidani","year":"2025","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.modpat.2026.101001_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cas.12396","article-title":"An inhibition of p62\/SQSTM1 caused autophagic cell death of several human carcinoma cells","volume":"105","author":"Nihira","year":"2014","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.modpat.2026.101001_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cell.2016.09.030","article-title":"p62 in cancer: signaling adaptor beyond autophagy","volume":"167","author":"Moscat","year":"2016","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.modpat.2026.101001_bib9","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/cam4.1093","article-title":"p62\/sequestosome 1 in human colorectal carcinoma as a potent prognostic predictor associated with cell proliferation","volume":"6","author":"Nakayama","year":"2017","journal-title":"Cancer Med"},{"issue":"9","key":"10.1016\/j.modpat.2026.101001_bib10","first-page":"10644","article-title":"Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"15","key":"10.1016\/j.modpat.2026.101001_bib11","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1158\/1078-0432.CCR-14-0620","article-title":"Cytoplasmic accumulation of sequestosome 1 (p62) is a predictor of biochemical recurrence, rapid tumor cell proliferation, and genomic instability in prostate cancer","volume":"21","author":"Burdelski","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.modpat.2026.101001_bib12","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.gendis.2021.03.008","article-title":"SQSTM1\/p62 regulate breast cancer progression and metastasis by inducing cell cycle arrest and regulating immune cell infiltration","volume":"9","author":"Qi","year":"2022","journal-title":"Genes Dis"},{"issue":"3","key":"10.1016\/j.modpat.2026.101001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24409","article-title":"SQSTM1\/p62 promotes the progression of gastric cancer through epithelial-mesenchymal transition","volume":"10","author":"Xu","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.modpat.2026.101001_bib14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cam4.4908","article-title":"SQSTM1\/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial\u2013mesenchymal transition and mitochondrial function maintenance","volume":"12","author":"Chen","year":"2023","journal-title":"Cancer Med"},{"issue":"10","key":"10.1016\/j.modpat.2026.101001_bib15","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.4161\/auto.32171","article-title":"Autophagy deficiency stabilizes TWIST1 to promote epithelial-mesenchymal-transition","volume":"10","author":"Qiang","year":"2014","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.modpat.2026.101001_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12020-023-03546-w","article-title":"SQSTM1\/p62 is a prognostic molecular marker and potential therapeutic target for pancreatic neuroendocrine tumours","volume":"85","author":"Song","year":"2024","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.modpat.2026.101001_bib17","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/ijms24043636","article-title":"The expression of autophagy-associated genes represents a valid footprint for aggressive pancreatic neuroendocrine neoplasms","volume":"24","author":"Matrood","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.modpat.2026.101001_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MPA.0000000000001478","article-title":"Intratumoral fibrosis and tumor growth pattern as prognostic factors in optimally resected pancreatic neuroendocrine neoplasms: an analysis of 168 cases","volume":"49","author":"Chatterjee","year":"2020","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.modpat.2026.101001_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.modpat.2026.101001_bib20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/cas.16060","article-title":"Immature stroma and high infiltration of CD15+ cells are predictive markers of poor prognosis in different subsets of patients with pancreatic cancer","volume":"115","author":"Yamada","year":"2024","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.modpat.2026.101001_bib21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41379-021-00995-4","article-title":"Infiltration pattern predicts metastasis and progression better than the T-stage and grade in pancreatic neuroendocrine tumors: a proposal for a novel infiltration-based morphologic grading","volume":"35","author":"Taskin","year":"2022","journal-title":"Mod Pathol"},{"issue":"29","key":"10.1016\/j.modpat.2026.101001_bib22","doi-asserted-by":"crossref","first-page":"22576","DOI":"10.1074\/jbc.M110.118976","article-title":"p62\/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription","volume":"285","author":"Jain","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.modpat.2026.101001_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccr.2011.12.006","article-title":"KrasG12D-induced IKK2\/\u03b2\/NF-\u03baB activation by IL-1\u03b1 and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma","volume":"21","author":"Ling","year":"2012","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.modpat.2026.101001_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/bjc.2014.355","article-title":"Prognostic significance of p62\/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma","volume":"111","author":"Liu","year":"2014","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2026.101001_bib25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.modpat.2026.101001_bib26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1387\/ijdb.082747rb","article-title":"A twist of insight - the role of Twist-family bHLH factors in development","volume":"53","author":"Barnes","year":"2009","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.modpat.2026.101001_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110909","article-title":"EMT, cancer stem cells and autophagy; The three main axes of metastasis","volume":"133","author":"Babaei","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"10.1016\/j.modpat.2026.101001_bib28","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1158\/1541-7786.MCR-13-0218-T","article-title":"The Twist box domain is required for Twist1-induced prostate cancer metastasis","volume":"11","author":"Gajula","year":"2013","journal-title":"Mol Cancer Res"},{"issue":"6","key":"10.1016\/j.modpat.2026.101001_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/diagnostics10060351","article-title":"Epithelial-mesenchymal transition proteins in neuroendocrine neoplasms: differential immunohistochemical expression in different sites and correlation with clinico-pathological features","volume":"10","author":"Guadagno","year":"2020","journal-title":"Diagnostics"},{"issue":"7441","key":"10.1016\/j.modpat.2026.101001_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature11910","article-title":"Autophagosomes form at ER-mitochondria contact sites","volume":"495","author":"Hamasaki","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.modpat.2026.101001_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.surg.2013.08.002","article-title":"Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors","volume":"155","author":"Crippa","year":"2014","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.modpat.2026.101001_bib32","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1210\/jc.2013-2604","article-title":"Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors","volume":"98","author":"Gaujoux","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.modpat.2026.101001_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13343","article-title":"European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours","volume":"35","author":"Kos-Kud\u0142a","year":"2023","journal-title":"J Neuroendocrinol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101001_bib34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.6004\/jnccn.2021.0032","article-title":"Neuroendocrine and adrenal tumors, version 2.2021","volume":"19","author":"Shah","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.modpat.2026.101001_bib35","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1038\/s41467-020-18504-7","article-title":"mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability","volume":"11","author":"Gremke","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.modpat.2026.101001_bib36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/onc.2016.202","article-title":"P62\/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA","volume":"36","author":"Xu","year":"2017","journal-title":"Oncogene"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522600044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522600044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T11:33:29Z","timestamp":1781696009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522600044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S089339522600044X"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101001","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"p62\/SQSTM1 Accumulation Defines an Epithelial-Mesenchymal Transition (EMT)\/Twist1-Associated Infiltrative Phenotype in Pancreatic Neuroendocrine Tumors","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101001"}}